PRUDENTIAL FINANCIAL INC

Position in ERAS — Erasca, Inc.

CIK 1137774 NEWARK, NJ

Position in ERAS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,742,448

+$6,695,000 QoQ

Shares Held

416,715

+3167.1% QoQ

Ownership

0.134%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.5920473225106.ToString("F0")% Shared 0.ToString("F0")% None 0.4079526774894112.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. ERAS ranks #17 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	140,491	$108,548,965
2	VRTX	Vertex Pharmaceuticals Inc / Ma	131,560	$58,746,801
3	INCY	Incyte Corp	374,280	$35,227,233
4	EXEL	Exelixis, Inc.	463,825	$19,893,454
5	LGND	Ligand Pharmaceuticals Inc	64,133	$12,804,153
6	ALMS	Alumis Inc.	538,733	$11,868,287
7	PTCT	Ptc Therapeutics, Inc.	164,570	$11,212,154
8	PTGX	Protagonist Therapeutics, Inc	95,235	$10,037,769

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,742,448	416,715	+3167.1%	Shares	Defined	2026-05-13
2025-12-31	$47,448	12,755	-29.8%	Shares	Defined	2026-02-13
2025-09-30	$39,590	18,161	0.0%	Shares	Defined	2025-11-13
2025-06-30	$23,064	18,161	+65.8%	Shares	Defined	2025-08-12
2025-03-31	$15,002	10,951	+5.6%	Shares	Defined	2025-05-13
2024-12-31	$26,031	10,371	0.0%	Shares	Defined	2025-02-11
2024-09-30	$28,312	10,371	-82.4%	Shares	Defined	2024-11-14
2024-06-30	$138,852	58,836	+54.9%	Shares	Defined	2024-08-13
2024-03-31	$78,230	37,976	—	Shares	Defined	2024-05-14
No filing history on record for this holder in this stock.